JUL 11, 2020 | BNT162, CALIFORNIA, COVID-19, LEADING SITES, MRNA-1273, NEWS, SITE SUCCESS, SITE WATCH, VACCINE
Paradigm Clinical Research Centers Inc. (Paradigm Research) in Redding, California, was selected to participate in both the Moderna mRNA-1273 and the Pfizer/BioNTech forthcoming Phase 3 BNT162 clinical trials. Paradigm Research is both a medical clinic and research site. Its founder and CEO, Dr. Jamshid Saleh who practiced neurosurgery for 22 years, stands clear about the importance of these vaccine trials. Forget politics and partisanship and whether one wears a mask or not; step up and prioritize community and patriotic duty above all else. Get out of the house, down to the clinic and volunteer to test these critical vaccine candidates. Introducing Redding, CA’s Paradigm Research and two forthcoming COVID-19 vaccine trials, involving Moderna’s mRNA-1273 and Pfizer’s BNT162.